Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy
Author(s) -
Eugènia Negredo,
Marta Massanella,
María C. Puertas,
María J. Buzón,
Jordi Puig,
Núria PérezÁlvarez,
Josué PérezSantiago,
Anna Bonjoch,
José Moltó,
Antoni Jou,
Patricia Echeverría,
Josep M. Llibre,
Javier MartínezPicado,
Bonaventura Clotet,
Julià Blanco
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt183
Subject(s) - raltegravir , viral load , cd8 , peripheral blood mononuclear cell , viral replication , t cell , immunology , integrase inhibitor , virology , biology , immune system , virus , medicine , antiretroviral therapy , in vitro , biochemistry
Immune hyperactivation in immunodiscordant patients can induce residual HIV replication and limit CD4 T cell recovery. We assessed the impact of raltegravir intensification on CD4 T cell recovery and viral persistence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom